Actinium Pharma (ATNM) – Hot Corp. News
-
Actinium Pharma (ATNM) Reports Update on Pivotal Phase 3 Trial of Iomab-B; 'Independent Data Monitoring Committee Recommends SIERRA Trial Continue'
-
Actinium Pharma (ATNM) Reports Promising Data on Labeling of Daratumumab with Radioisotope Actinium-225
-
-
-
-
-
-
-
-
-
-
-
-
Back to ATNM Stock Lookup